Ledger.Open graph →

SEC Form D · filed May 2, 2016

ViewPoint Therapeutics, Inc

Offering

$4.0M

Sold

$4.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Leah Makley · San Francisco, CAExec · Director Douglas T. Crawford · San Francisco, CADirector Ed Hurwitz · San Francisco, CAExec · Director Emmett T. Cunningham, Jr · San Francisco, CADirector Susan Bailey · Fort Collins, COExec · Director Robert E. Enslein, Jr · New York, NYExec · Director Douglas K. Crawford · San Francisco, CADirector Glen C. Dailey · New York, NYDirector Jason E. Gestwicki · San Francisco, CADirector Mark T. Blumenkranz, M.D · San Francisco, CADirector Jason Pizzorusso · New York, NYDirector Robert K. Lewis · Austin, TXExec · Director Raul C. Romero · Austin, TXDirector Michelle G. Gottlieb · Chicago, ILExec · Director Jason E. Gestwicki · San Francisco, CADirector Mark T. Blumenkranz, M.D · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗